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INTRODUCTION
Breast implant rupture is one of the most serious complications 
and concerns of patients. Both manufacturers and physicians 
commonly explain that breast implants are semi-permanent. 
However, according to the United States Food and Drug Admin-
istration (US FDA) classification, breast implants have a limited 
product-life. In practice, a breast implant device can maintain its 
mechanical integrity for decades in a woman’s body, but the inci-
dence of rupture increases with time [1]. Upon saline breast im-
plant rupturing or leaking, it quickly deflates, which is noticed by 
the patient. By contrast, rupture of a silicone breast implant does 
not usually produce a change in volume, and the patient general-
ly cannot realize what has happened in her body [2].
Rupture rates for both saline and silicone breast implants were 
generally greater than 10% before the development of fifth-gener-
ation silicone gel implants, namely, cohesive gel silicone implants 
[3,4]. The reported mechanisms of breast implant rupture in-
clude iatrogenic damage, trauma, chemical degradation of the im-
plant shell, and mechanical pressure during mammography [5].
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Through the analysis of cases of ruptured implants, one can 
obtain valuable information about the type of ruptured implant, 
duration of implantation before rupture, degree of capsular con-
tracture, rupture-associated symptoms, and tools to diagnose 
ruptured implants. To accomplish this, we examined 72 rup-
tured breast implants after breast augmentation or reconstruc-
tion surgery. We described the relationship between the type of 
implant and the symptoms associated with a ruptured implant, 
and evaluated the ruptured period and related assessments. We 
determined the risk of implant rupture and recommended an 
approach for follow-up of patients with breast implants.
METHODS
This study involved a retrospective review of 72 implants, which 
were removed for suspected implant rupture between 2005 and 
2014 at a single institution. The following data were collected 
for all cases involving both saline and silicone implants: age at 
rupture diagnosis, duration of implantation before rupture, type 
of implant shell, degree of capsular contracture, associated 
symptoms, cause of rupture, tools used to diagnose implant 
rupture, and management of ruptured implants. Additionally, 
we analyzed the degree of filling of the saline implants and the 
type of rupture in the silicone implants.
Shell type was classified as textured, smooth, or unknown (un-
recorded). Depending on the deformation of the breast contour, 
capsular contracture was classified according to the Baker sys-
tem as grade I, II, III, or IV. Patients’ symptoms were classified 
as size change, skin change, palpable mass, or no symptoms. 
The cause of rupture was classified as spontaneous, associated 
with deformity, or iatrogenic. The diagnostic tools used were ei-
ther ultrasonography or magnetic resonance imaging (MRI). If 
rupture was confirmed by a surgical procedure without any di-
agnostic tools, we indicated that the diagnosis was made by 
symptoms alone. For the method of treatment, we specified 
whether the patient underwent an implant change, microfat 
graft, removal only, and follow-up loss.
Many ruptures of breast silicone implants produced no symp-
toms, and thus, screening tests and MRI findings were used to 
identify the implant rupture. This study also compared the MRI 
findings with clinical symptoms and operative findings. During 
MRI of the breast with a shell rupture, a concave line called the 
“Linguine” sign was identified, and the rupture was thereby clas-
sified as either intra-capsular or extra-capsular.
RESULTS
The age of the subjects when the implant rupture was diagnosed 
ranged from 38 to 52 years. Of the 72 ruptured implants, 45 oc-
curred in saline implants, and 27 occurred in silicone implants. 
Each ruptured implant was categorized according to the type of 
implant; the characteristics of the two implant groups are shown 
in Table 1.
For the saline implants, the mean duration of implantation be-
fore diagnosis of the rupture was 5.6 years. The shell type of the 
ruptured saline implant was textured for 16 cases and smooth for 
25 cases. If there were no medical records, the shell type was clas-
sified as unknown. Capsulectomy was performed simultaneously 
in 10 cases, and the following capsular grades were noted: grade I, 
23 cases; grade II, 12 cases; grade III, 7 cases; and grade IV, 3 cas-
es. The purpose of implantation was augmentation and recon-
struction for 15 and 30 cases, respectively (Table 1). The most 
common associated symptom in saline implants rupture was size 
change; other symptoms were much less common. Rupture was 
primarily diagnosed on the basis of symptoms. Ultrasonography 
and MRI were much less frequently used for diagnosis. The 
cause of rupture was predominantly spontaneous in 28 cases, as-
sociated with a deformity in 11 cases, and iatrogenic in 6 cases. 
Capsular contracture of grade III or greater accompanied by de-
formity was classified as associated with deformity; ruptures oc-
curring during the actual surgery and 6 months after surgery 
were classified as iatrogenic. The treatment of the rupture was 
implant change in 35 cases, microfat graft in 2 cases, removal in 2 
cases, and nothing in 6 cases. Forty percent of implants were re-
placed by the same material, whereas 60% of implants were re-
placed with silicone (Table 2). The degree of implant filling was 
most commonly found to be too low (Table 3).
For the silicone implants, the mean duration of implantation 
until rupture was 12 years. Capsulectomy was executed simulta-
Characteristic Saline (n=45)
Silicone 
(n=27)
Mean age at diagnosis of ruptured implant (yr) 48 49
Mean duration of implant placement (yr) 5.6 12
Shell type (n)
   Textured 16 11
   Smooth 25 4
   Unknown 4 12
Capsule Baker stage (n)
   Grade I 23 8
   Grade II 11 16
   Grade III 8 2
   Grade IV 3 1
Purpose of implantation (n)
   Augmentation 15 25
   Reconstruction 30 2
Table 1. Patient and breast implant characteristics of 72 
ruptured breast implants
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neously in 4 cases, and the capsule was graded as follows: grade 
I, 8 cases; grade II, 15 cases; grade III, 3 cases; and grade IV, 1 
case. Two cases involved reconstruction, and 25 involved aug-
mentation surgery. Approximately half of the ruptured silicone 
implant cases had a history of mammoplasty (Table 1).
For the silicone implants, the most common symptoms of 
rupture were palpable mass and no symptoms. Fourteen cases 
(52%) were diagnosed by MRI, and each reading was found to 
indicate the opinion as follows (Table 1). Before a rupture was 
confirmed in silicone implants, a follow-up MRI identified the 
rupture by implant folding and both intra- and extracapsular 
signs of rupture. The most common location of rupture was in-
tra-capsular (15 cases), followed by gel bleed and extra-capsular 
rupture (6 cases each) (Table 4). Bleeding of the gel, as ob-
served on the image, was not a clear sign of rupture, but if the 
patient showed symptoms such as tenderness or palpable mass, 
rupture was diagnosed, which was confirmed after removal of 
the implant. Fig. 1 shows an example of an MRI image of a rup-
tured silicone implant. Fig. 2 shows a photograph of the rup-
tured silicone implant after removal from the body. Treatment 
after rupture involved implant change in 4 cases, implant re-
moval in 12 cases, and no treatment in 11 cases. All changes to 
implants were performed using silicone implants (Table 2). 
DISCUSSION
Use of first-generation silicone breast implants was initially re-
ported by the plastic surgeons, Cronin and Gerow [6] in 1962. 
These silicone breast prostheses, manufactured by Dow Corn-
ing Corporation, were filled with moderately viscous silicone 
Degree of saline implant filling Saline
Underfilling 26
Adequate 7
Overfilling 4
Unknown 8
Table 3. Degree of filling of saline implants
Characteristic Saline(n=45) 
Silicone
(n=27)
Symptom
   Size change 40 (80) 6 (17)
   Skin change 3 (6) 6 (17)
   Palpable mass 6 (12) 14 (39)
   No symptom 1 (2) 10 (27)
Cause
   Spontaneous 28 (62) 20 (74)
   Associated with deformity 11 (24) 3 (11)
   Iatrogenic 6 (14) 4 (15)
Diagnostic tool
   Symptoms only 36 (80) 0 (0)
   Ultrasonography 5 (11) 13 (48)
   Magnetic resonance imaging 4 (9) 14 (52)
Treatment
   Implant change 35 (78) 4 (15)
      Saline 14 (40) 4 (100)
      Silicone 21 (60) 0 (0)
   Microfat graft 2 (4) 0 (0)
   Removal only 2 (4) 12 (44)
   No treatment 6 (14) 11 (41)
Values are presented as number (%). Multiple assessments were possible be-
tween each symptom.
Table 2. Symptoms, causes, diagnostic tools, and treatment 
of ruptured implants
Type of rupture Silicone
Gel bleeda) 6
Intracapsular 15
Extracapsular 6
a)Gel bleeding was confirmed during surgery.
Table 4. Type of rupture of silicone implants
An example of an magnetic resonance imaging of a ruptured sili-
cone implant.
Fig. 1. “Linguine” sign
A photograph of the ruptured silicone implant after removal from 
the body.
Fig. 2. Ruptured implants
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gel [6]. Fifth-generation silicone gel implants are currently in 
use, which are made of cohesive silicone gel that typically elimi-
nates filler gel leakage. Saline breast implants, filled with saline 
solution, were first developed by a French company in 1965 [7]. 
Although silicone implants require an invasive surgical tech-
nique requiring a long surgical incision, the technical goal of us-
ing the saline-filled implant was to develop a less-invasive surgi-
cal method for inserting an empty implant through a short sur-
gical incision.
Insertion of a breast implant is a common method of breast 
augmentation and reconstruction surgery, and rupture is a po-
tential complication of all breast implants. Currently available 
breast implants have different shell thickness. It is difficult to 
compare types of breast implants according to a standardized 
measurement, but they can be compared on the basis of number 
of years used and implant durability [8]. The most substantial 
difference between saline implants and silicone implants is their 
ease with which a rupture can be detected, if it occurs. In the 
numerous studies that have evaluated risk factors for implant 
rupture, spontaneous rupture has been identified as the main 
cause of breast implant rupture [9].
Rupture/deflation rates of 3% to 5% and 7% to 10% have been 
reported at 3 years and 10 years after insertion of saline breast 
implants, respectively [3]. Studies on the lifespan of saline im-
plants by Natrelle have shown that rupture occurs in 10% of 
these implants during the first 10 years after insertion [3]. This 
figure can be expected to rise, since the mean time to rupture in 
our study was approximately 5.6 years. Furthermore, our find-
ing of 48 years old as the mean age when rupture is diagnosed 
suggests that, considering an average woman’s life expectancy of 
84.6 years, a saline implant will require replacement in more 
than 70% of users during their lifetime [10]. Thus, each institu-
tion must closely observe their patients with saline implants. 
According to the analysis of shell type, saline implant rupture 
occurred at a higher frequency with a smooth type. However, 
we did not control other factors like total number of cases, so 
the results are not statistically significant. Capsular contracture 
was not used to determine relevance. In a previous study, the 
shell type of the breast implant was not related to the degree of 
capsular contracture [11]. Differences in rupture cases between 
augmentation and reconstruction were attributed to the differ-
ent numbers of each case. According to a previous study, the im-
plant rupture rate was not statistically significant with regard to 
the purpose of implantation (Table 1) [12]. Saline implant rup-
ture has been previously reported as being identified and lead-
ing to a doctor’s visit primarily by the symptom of “sizing down” 
[13]. In our study, the diagnosis of saline implant rupture was 
generally accomplished by noting symptoms alone, and the im-
plant change rate was high because size change was the most 
frequent complication. Because a major complication of im-
plantation is a decrease in breast volume, the choice of treat-
ment is to change the implant upon saline implant rupture. Phy-
sicians recommend replacement using the same type of previ-
ously implanted material or cohesive gel. However, the final se-
lection of the implant type and other treatments was only con-
firmed after consultation with the patient. For patients who re-
fused the re-insertion of the implant, the implant was removed 
(Table 2). Furthermore, we observed that ruptured saline im-
plants were associated with under-filling in many instances; 
however, over-filling and adequate filling were present in ap-
proximately 30% of all cases of implant rupture for which the 
degree of filling was recorded (Table 3). Authors of a previous 
study of breast reconstruction suggested that the frequent oc-
currence of under-filling indicates that under-filling itself is a 
risk factor for rupture. In that study, although 30% of all im-
plants were under-filled, under-filling was noted in 70% of rup-
tured implants. Thus, in the presence of under-filling, the prob-
ability of rupture was increased. Other studies have also sug-
gested that risk factors for saline implant rupture include under-
filling, possibly by leading to shell folding [14].
For silicone implants, ruptures were identified at a mean of 12 
years after insertion, which was substantially longer than the 
time for saline implants. This is probably related to the silicone 
shell being thicker than the saline implant’s shell, and the silicone 
shell’s lower likelihood of being damaged during implantation. 
However, rupture of silicone implants is generally not accompa-
nied by the simultaneous occurrence of symptoms [15]. The 
rupture itself is usually detected during the process of routine 
follow-up visits, and when identified in our study, it was primari-
ly at the intra-capsular rupture stage. Gel bleed was not associat-
ed with any particular symptoms, and it was thus identified dur-
ing check-ups [4]. Because gel bleed occurs without noticeable 
symptoms, it will frequently develop into an intra- or even extra-
capsular rupture, requiring not only implant removal but often 
also other procedures. Indeed, additional procedures, such as 
capsulectomy and foreign body removal, were often performed. 
A previous study noted that screening tests for silicone implant 
rupture identified almost 1.9% [16]. Patients in our study were 
also suspected during checkups of having a rupture, but because 
of a lack of relevant symptoms, no procedure was applied in 41%. 
This can often lead to capsular contracture, siliconoma, and oth-
er complications [17]. In cases of ruptured silicone implants, the 
patients and physician chose implant removal rather than im-
plant re-insertion, because long-term complications like skin col-
or change and a palpable mass were unacceptable to the patient 
(Table 2). Untreated silicone breast implants have likewise been 
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identified in numerous studies as a risk factor for immunologic 
disorders [18]. The poly implants prostheses (PIP) crisis is an 
example of problems associated with a particular type of prefilled 
silicone breast implant: in March 2010, the French government 
suspended the sale of PIP because of a high failure rate and be-
cause of the use of an inappropriate silicone gel [19].
The physical examination is inadequate for correctly evaluat-
ing whether a breast implant has ruptured. In asymptomatic pa-
tients, only 30% of ruptured breast implants are accurately de-
tected by palpation by an expert plastic surgeon [20]. In this 
study, the diagnosis of saline implant rupture was frequently 
confirmed by changes in the size of the breast. Cases of silicone 
implant rupture were primarily confirmed using US and MRI. 
(Table 2) Therefore, many women do not undergo immediate 
treatment, and more serious complications can consequently 
arise. The US FDA recommended routine MRI examinations 
for screening of silent rupture of silicone gel breast implants at 3 
years post-implantation and then every 2 years thereafter [21]. 
MRI is the best diagnostic tool to detect a silicone breast im-
plant rupture. MRI findings are similar to those found during 
surgery. The MRI signs of rupture have been analyzed exten-
sively studied and important signs, such as the “Linguine” signs, 
have been identified (Fig. 1). According to long-term MRI data, 
silicone gel breast implants are associated with silent rupture 
rates of 9% to 12% at 8 years postimplantation [4]. However, 
the shell of a cohesive gel implant is firmer than that of previous 
implants, and this filler has a higher viscosity, ranging between 
that of a liquid and solid. The silicone inside a cohesive gel im-
plant does not flow like water. It will not squirt, or even run free-
ly, even if the tough outer shell is punctured. The cohesive gel 
tends to remain together. A study of the safety and effectiveness 
of cohesive gel implants reported low device rupture rates: only 
1.1% at 6 years post-implantation for primary breast augmenta-
tion surgery patients [22].
MRI evaluation is expensive, so MRI scans are often obtained 
only when women have symptoms, or when suggestive findings 
are noted on other diagnostic tools, such as an ultrasonic study 
or mammogram [9]. Most detected silicone implant ruptures 
are found by periodic evaluation for breast cancer. There seem 
to be many instances of hidden rupture that cause no apparent 
symptoms. Many ruptured implants exhibited gel bleed and 
tears, but in those implants retained for over 10 years, many also 
showed shell thinning (Fig. 2). A breast implant study investi-
gating the anticipated life of silicone implants noted that silicone 
rupture occurred at a mean patient age of 50 years old. Silicone 
implants inserted previously should be replaced with fifth-gen-
eration cohesive gel before rupture occurs due to shell thinning. 
If one waits until symptoms of silicone rupture occur, additional 
procedures and operation time are also increased [17].
Ruptured saline implants have a short life span, but ruptures 
are easier and safer to diagnose, leading to fewer complications. 
Rupture of previous-generation silicone implants is often hid-
den, but it may lead to problems at any time, including an in-
creased risk of cancer. For these older silicone implants, close 
follow-up is required, in an effort to detect deterioration before 
rupture occurs. Consideration should be given to changing these 
older silicone implants to a cohesive gel silicone implant. Cohe-
sive breast implants appear to offer major advantages over their 
predecessors, but they have been in use for less than 10 years, so 
further studies are required to evaluate their long-term effects.
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